
HCAT Stock Forecast & Price Target
HCAT Analyst Ratings
Bulls say
Health Catalyst is a leading player in the healthcare analytics market, with its integrated data analytics solution and high-end professional services setting it apart from competitors. Despite current economic uncertainty and budget pressures in the healthcare sector, the company's successful ramp of Tech-Enabled Managed Services contracts and competitive positioning present a favorable outlook for future growth and profitability. The company's focus on migrating clients to its more robust and flexible Ignite platform also bodes well for sustainable growth and margin expansion in the long term.
Bears say
Health Catalyst is facing challenges with customer retention and potential downsells due to the transition from DOS to Ignite, resulting in a decrease in ARR and potential churn in the coming years. However, the company has shown some success with new customer acquisitions and has potential in its VitalWare application assets, which could generate significant revenue and profit. But with a negative outlook on the company's potential risks and challenges, it is difficult to determine the likelihood of long-term success.
This aggregate rating is based on analysts' research of Health Catalyst Inc and is not a guaranteed prediction by Public.com or investment advice.
HCAT Analyst Forecast & Price Prediction
Start investing in HCAT
Order type
Buy in
Order amount
Est. shares
0 shares